Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 17 (6) , 1091-1098
- https://doi.org/10.1016/0149-2918(95)80087-5
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Efficacy of Oral Ondansetron in the Prevention of Emesis in Outpatients Receiving Cyclophosphamide-based ChemotherapyAnnals of Internal Medicine, 1993
- The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom controlCancer Treatment Reviews, 1991
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983